JPMorgan Upgrades Corteva Following Spinoff of Seed Business
Corteva is expected to see significant gains as it shifts focus toward its crop chemical business, according to JPMorgan. The investment bank upgraded the stock from neutral to overweight and set a $19 price target, implying 53% upside potential based on Monday's closing price. This follows Corteva’s recent spinoff of its seed division into Vylor, which is intended to streamline operations around agricultural chemicals. JPMorgan analyst Jeffrey Zekauskas noted that the company plans to in-license new crop chemical molecules with strong growth and margin profiles. He also highlighted improving corn prices as a potential catalyst for better pricing trends by 2027. Despite ongoing legal challenges, including lawsuits related to 'forever chemicals,' JPMorgan believes Corteva is undervalued at current levels. The upgrade aligns with broader analyst sentiment; of the 23 analysts covering Corteva, 15 have a buy or strong buy rating.
Tickers: $CTVA
Topics: agricultural commodities Corteva crop chemicals JPMorgan upgrade